ConductScience.org, home

Paper38540684

Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms.

Al Musaimi O. Biomolecules, 2024. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms. Papers, record 38540684. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38540684

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms.
PubMed
Journal
Biomolecules
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
7.16, provisional
iCite
Revised in PubMed
2026-04-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Al Musaimi OOthmanhttps://orcid.org/0000-0003-2421-1825

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenocorticotropic HormoneMajor topic
alpha-MSHMajor topic
United States
Cholecystokinin
Glucagon-Like Peptide 1
United States Food and Drug Administration
Melanocyte-Stimulating Hormones
Transcription Factors

Source PubMed

Download CSV of topics

References88

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127313432Dulaglutide (Trulicity): The Third Once-Weekly GLP-1 Agonist.P T2016https://conductscience.org/library/papers/27313432PubMed
2297359132017 FDA Peptide Harvest.Pharmaceuticals (Basel)2018https://conductscience.org/library/papers/29735913PubMed
319627167Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.BioDrugs2009https://conductscience.org/library/papers/19627167PubMed
425332973The physiological roles of secretin and its receptor.Ann Transl Med2013https://conductscience.org/library/papers/25332973PubMed
525140322Alpha-melanocyte stimulating hormone: an emerging anti-inflammatory antimicrobial peptide.Biomed Res Int2014https://conductscience.org/library/papers/25140322PubMed
620440595Nutrient regulation of enteroendocrine cellular activity linked to cholecystokinin gene expression and secretion.J Physiol Biochem2010https://conductscience.org/library/papers/20440595PubMed
729736023MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency.Nat Med2018https://conductscience.org/library/papers/29736023PubMed
829031731Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency.Mol Metab2017https://conductscience.org/library/papers/29031731PubMed
927288825PCSK1 Variants and Human Obesity.Prog Mol Biol Transl Sci2016https://conductscience.org/library/papers/27288825PubMed
101326760Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.Proc Natl Acad Sci U S A1992https://conductscience.org/library/papers/1326760PubMed
11321510512019 FDA TIDES (Peptides and Oligonucleotides) Harvest.Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/32151051PubMed
1212049668The diversity of acetylated proteins.Genome Biol2002https://conductscience.org/library/papers/12049668PubMed
1367777744-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6777774PubMed
1430067154Mechanisms of Insulin Action and Insulin Resistance.Physiol Rev2018https://conductscience.org/library/papers/30067154PubMed
152164192Chemical pathways of peptide degradation. I. Deamidation of adrenocorticotropic hormone.Pharm Res1990https://conductscience.org/library/papers/2164192PubMed
1629397376Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial.Lancet Diabetes Endocrinol2018https://conductscience.org/library/papers/29397376PubMed
178575558The history of cyclosporin A (Sandimmune) revisited: another point of view.Experientia1996https://conductscience.org/library/papers/8575558PubMed
1817380212Mecasermin rinfabate.Drugs Today (Barc)2007https://conductscience.org/library/papers/17380212PubMed
1935940656The Vexing Voyage of Vasopressin: The Consequences of Granting Market Exclusivity to Unapproved Drugs.Chest2022https://conductscience.org/library/papers/35940656PubMed
2011294822Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.Endocr Rev2001https://conductscience.org/library/papers/11294822PubMed

See all 88 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
42653761Phage Display as a Promising Platform for Peptide Drug Discovery.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653761PubMed
42515672Peptide Hormones in Appetite Regulation: A Complex Network.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42515672PubMed
42405758Gut microbiota as key mediators of animal acclimation to temperature changes: mechanisms and interventions.Appl Environ Microbiol2026https://conductscience.org/library/papers/42405758PubMed
42311743Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and Clinical Outcomes.Cureus2026https://conductscience.org/library/papers/42311743PubMed
42153319Contemporary data-driven innovations in peptide-based therapeutic design.Brief Bioinform2026https://conductscience.org/library/papers/42153319PubMed
41726332OBIMAP (One-Bead Interchain Multipeptide Assembly Platform).ACS Bio Med Chem Au2026https://conductscience.org/library/papers/41726332PubMed
41471111Oral Treatment of Obesity by GLP-1 and Its Analogs.Pharmaceutics2025https://conductscience.org/library/papers/41471111PubMed
40741609Therapeutic peptides and their delivery using lipid-based nanoparticles.Tzu Chi Med J2025https://conductscience.org/library/papers/40741609PubMed
40720534A Computational Perspective to Intermolecular Interactions and the Role of the Solvent on Regulating Protein Properties.Chem Rev2025https://conductscience.org/library/papers/40720534PubMed
40607385Immunogenicity of therapeutic peptide products: bridging the gaps regarding the role of product-related risk factors.Front Immunol2025https://conductscience.org/library/papers/40607385PubMed
40604960Protease production by Serratia liquefaciens NRC1 using fish gut waste as a sustainable approach to antimicrobial peptide generation and combating Candida auris acquired resistance.Microb Cell Fact2025https://conductscience.org/library/papers/40604960PubMed
40341735Assessment of ghrelin serum level and gene polymorphism as a risk factor in progression of chronic viral hepatitis.Sci Rep2025https://conductscience.org/library/papers/40341735PubMed
401430702024 FDA TIDES (Peptides and Oligonucleotides) Harvest.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40143070PubMed
40076641Study of Intracellular Peptides of the Central Nervous System of Zebrafish (Danio rerio) in a Parkinson's Disease Model.Int J Mol Sci2025https://conductscience.org/library/papers/40076641PubMed
40006605Advances in Oral Biomacromolecule Therapies for Metabolic Diseases.Pharmaceutics2025https://conductscience.org/library/papers/40006605PubMed
39921384Regulatory Guidelines for the Analysis of Therapeutic Peptides and Proteins.J Pept Sci2025https://conductscience.org/library/papers/39921384PubMed
39883351Growth hormone-releasing hormone signaling and manifestations within the cardiovascular system.Rev Endocr Metab Disord2025https://conductscience.org/library/papers/39883351PubMed
39598608Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation.Pharmaceutics2024https://conductscience.org/library/papers/39598608PubMed
39570567Effects of GHRH and its analogues on the Vascular System.Rev Endocr Metab Disord2025https://conductscience.org/library/papers/39570567PubMed
39560873GHRH in diabetes and metabolism.Rev Endocr Metab Disord2025https://conductscience.org/library/papers/39560873PubMed

See all 22 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCK885PubTator's text mininghttps://conductscience.org/library/genes/885NCBI Gene
GHRH2691PubTator's text mininghttps://conductscience.org/library/genes/2691NCBI Gene
GIP2695PubTator's text mininghttps://conductscience.org/library/genes/2695NCBI Gene
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
POMC5443PubTator's text mininghttps://conductscience.org/library/genes/5443NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38540684

GET https://conductscience.org/api/papers/v1/38540684/references?page=2